Good evening and welcome to Markets Desk, your end-of-day read on what moved the needle today.
Russia took a significant step toward institutionalizing crypto, allowing Bitcoin trading on exchanges beginning November twenty-second, pending central bank approval of trading rules. Moscow Exchange is targeting a December first pilot through its sanctioned clearinghouse, though retail investors face a cap of three hundred thousand rubles in annual purchases per intermediary, and Bitcoin remains unusable as a payment method.
Shifting to healthcare and a story with real market implications, a Mayo Clinic analysis of more than two hundred fifty thousand patient records suggests GLP-one drugs may outperform metformin in reversing prediabetes and reducing cardiovascular risk. That adds meaningful weight to an already crowded bull case for Novo Nordisk and Eli Lilly, and could accelerate prescribing well beyond the obesity indication that first drove these names higher.
On the equity side, the S and P five hundred heads into Thanksgiving week trading below its recent peak, though history offers some comfort. Since nineteen fifty, the index has finished the holiday week higher in fifty-three of seventy-six years, with an average gain of roughly seven tenths of one percent, making it a historically constructive stretch even in softer tape conditions.
That's the tape. Markets Desk, signing off the floor.
